SUMMARY DNA interstrand crosslinks (ICLs) that are repaired in non-dividing cells must be recognized independently of replication-associated DNA unwinding. Using cell-free extracts from Xenopus eggs that support neither replication nor transcription, we establish that ICLs are recognized and processed by the mismatch repair (MMR) machinery. We find that ICL repair requires MutSa (MSH2-MSH6) and the mismatch recognition FXE motif in MSH6, strongly suggesting that MutSa functions as an ICL sensor. MutSa recruits MutLa and EXO1 to ICL lesions, and the catalytic activity of both these nucleases is essential for ICL repair. As anticipated for a DNA unwinding-independent recognition process, we demonstrate that least distorting ICLs fail to be recognized and repaired by the MMR machinery. This establishes that ICL structure is a critical determinant of repair efficiency outside of DNA replication.
INTRODUCTION
DNA interstrand crosslinks (ICLs) are lesions that covalently link opposing strands of the double helix. ICLs physically block cellular processes that require the unwinding of the DNA molecule, such as replication, recombination, and transcription. ICLs can also interfere with essential protein-DNA binding events such as transcription factor binding. Chemicals that induce ICLs, such as nitrogen mustards, platinum drugs, and mitomycin C are therefore extremely cytotoxic and are routinely used in the clinic as anti-cancer chemotherapies (Deans and West, 2011) . Importantly, ICLs also arise as a consequence of cellular metabolism, for instance, through production of reactive aldehydes such as malondialdehyde, acetaldehyde, and formaldehyde (Duxin and Walter, 2015) or by chemical rearrangements at abasic DNA sites (Price et al., 2014) .
ICLs vary greatly in structure and the degree to which they distort DNA. These structural differences can influence the manner in which cells process the ICLs. Indeed, in yeast, the repair pathway that responds to crosslinking damage differs according to the crosslinking drug (Beljanski et al., 2004) . In mammalian cells, the efficiency of ICL unhooking and repair is greater for a distorting ICL than for a non-distorting ICL (Hlavin et al., 2010; Smeaton et al., 2008) . Furthermore, at least two replication-coupled ICL repair mechanisms have been described in Xenopus extracts for which the primary determinant of repair pathway choice is based on ICL structure (Semlow et al., 2016) .
In proliferating cells, most repair occurs during S-phase, when ICL sensing is a direct consequence of replication. Active replisomes stall at ICLs and trigger a complex reaction that requires the Fanconi anemia (FA) proteins (Ben-Yehoyada et al., 2009; Klein Douwel et al., 2014; Knipscheer et al., 2009; Rä schle et al., 2008) or the NEIL3 glycosylase (Semlow et al., 2016) . Non-dividing yeast cells grown to stationary phase (Sarkar et al., 2006) and G1-arrested mammalian cells (Hlavin et al., 2010; Muniandy et al., 2009; Shen et al., 2006) harness an alternative modality of repair termed replication independent repair (RIR) (Williams et al., 2012) . To date, the molecular components that contribute to RIR have not been fully defined. A fundamental question that remains unanswered is how ICLs are recognized without replisome/ICL clashes. Collision between the transcription machinery and ICLs could activate repair. Indeed, ICLs are more efficiently processed when placed in transcribed regions (Islas et al., 1991) , and repair of ICLs placed in constitutively transcribing plasmids shows dependence for transcription-coupled and global-genome nucleotide excision repair proteins (Enoiu et al., 2012) . However, RIR is initiated in Xenopus extracts in the absence of both replication and transcription (Ben-Yehoyada et al., 2009; Williams et al., 2012) , suggesting ICLs can be directly funneled into a repair pathway by DNA damage sensor proteins. But no ICL sensor has yet been unambiguously identified, and it is not clear how structurally distinct ICL lesions are recognized and/or subsequently repaired during RIR.
The mismatch repair (MMR) pathway is a highly conserved DNA repair mechanism that primarily functions to correct replication errors that escape proofreading. MMR is initiated by the MutSa complex (MSH2-MSH6 heterodimer), which recognizes and binds single base mismatches and 1-2 base insertion-deletion loops (IDLs). Binding of MutSa to mispaired bases leads to the recruitment of downstream DNA repair proteins including the MutLa endonuclease (MLH1-PMS2 heterodimer), replication protein A (RPA), EXO1, and proliferating cell nuclear antigen (PCNA). Together, these proteins catalyze an excision-repair reaction to restore proper Watson-Crick base-pairing and can effectively increase the fidelity of replication by up to three orders of magnitude. In humans, mutations in either subunit of MutSa (MSH2 and MSH6) account for 50%-60% of germline mutation-based (Lynch syndrome) and 15%-20% of sporadic colorectal cancers (Reyes et al., 2015) .
Importantly, MutSa has multiple roles outside of replication. MutSa is active in quiescent (post-mitotic) mammalian cells, such as terminally differentiated neurons, where the complex participates in genome maintenance mechanisms by recognizing not only canonical DNA mismatches, but also responding to chemically modified DNA bases (Iyama and Wilson, 2013; Schroering et al., 2007) . For example, plasmids containing single O 6 -methyl-guanine adducts (O6meG) are processed in a MutSa-dependent fashion in non-replicating mammalian (York and Modrich, 2006) and Xenopus extracts (Olivera Harris et al., 2015) , although leading sometimes to futile repair cycles (Fu et al., 2012) . In addition to O6meG, MutSa specifically recognizes bulky lesions such as O4-methylthymine adducts and cisplatin intrastrand crosslinks in vitro. Crystal structures of human MutSa bound to these DNA substrates reveal a common mechanism of damage recognition that requires an N-terminal FXE motif found in the MSH6 subunit (Warren et al., 2007) . Binding of MutSa to DNA lesions leads to a variety of cellular outcomes including repair, checkpoint activation, and apoptosis, underscoring the versatile and critical role that MutSa plays in genome maintenance. In this study, we demonstrate a role for the MMR machinery in ICL repair. Using non-replicating and transcriptionally silent Xenopus extracts, we show that MutSa binds to plasmids bearing a single site-specific ICL and harnesses the entire MMR machinery, including the MutLa and EXO1 nucleases, to perform ICL repair. We also compare the repair of structurally different ICLs, including two analogs of the malondialdehyde ICL and a nitrogen mustard-like ICL (Guainazzi et al., 2010) . We conclude that ICL structure influences lesion recognition and repair efficiency during RIR.
RESULTS

MutSa (MSH2-MSH6) Senses DNA ICLs
The MutSa complex recognizes a diverse array of aberrant DNA structures including base-base mispairs and chemically modified DNA adducts. We hypothesized that the ability of MutSa to recognize distortions within DNA might also extend to ICLs, and that sensing of ICLs by MutSa could initiate ICL repair by a set of reactions analogous to MMR. To test this hypothesis, we first asked whether MutSa binds preferentially to ICLs in non-replicating Xenopus extracts (high-speed supernatant [HSS] ) using a plasmid pull-down assay. Notably, these cellfree extracts support ICL repair and restore the integrity of both DNA strands (Williams et al., 2012) .
We used SJG-136, a rationally designed crosslinking drug, to generate plasmids with a single site-specific ICL lesion. SJG-136 preferentially forms ICLs between guanine residues at 5 0 -purine-GATC-pyrimidine-3 0 sequences ( Figure S1A ) (Gregson et al., 2001) . We treated oligonucleotide duplexes containing a single SJG-136 reaction site ( Figure S1B ) and purified crosslinked duplexes by denaturing PAGE. These oligos were ligated into a small plasmid (pBS: pBlueScript) and further purified by cesium chloride density ultracentrifugation.
Following incubation in HSS, we isolated plasmid and plasmid-bound proteins from the extract using biotinylated lac repressor protein and streptavidin beads, as previously described (Williams et al., 2012) . Western blot analysis revealed that the crosslinked plasmid was enriched in bound MSH2 and MSH6 when compared to identical undamaged control plasmids ( Figure 1A) .
In order to study the dose-dependent response of MutSa to crosslinks, we conducted a similar experiment with plasmids containing multiple ICLs by treating double-stranded pBS plasmids in vitro with increasing doses of SJG-136 (Figures S1C-S1E). We observed dose-dependent increase of MSH2 and MSH6 binding to damaged plasmids ( Figure 1B ), after normalizing for plasmid recovery using qPCR ( Figure S1F ). We also observe the recruitment of PCNA and RPA to these plasmids in a dose-dependent manner, suggesting that the crosslinked plasmids were undergoing processing and repair. Consistent with the accumulation of RPA and with our previous studies (Ben-Yehoyada et al., 2009; Williams et al., 2012) , incubation of the SJG-136-treated plasmids in HSS triggered phosphorylation of cytosolic Chk1 ( Figure S1G ), a marker for ataxia telangiectasia and Rad3-related kinase (ATR) checkpoint activation.
Next, we asked whether MutSa is required for ICL repair. ICL plasmids harboring a single, site-specific trimethylene ICL lesion (5 0 GpC-ICL), for which a nuclear magnetic resonance (NMR) structure has been described were used as substrates (Protein Data Bank [PDB]: 2KNL) (Dooley et al., 2003) . In contrast to the temperature-sensitive ICLs generated by SJG-136, the trimethylene crosslink is extremely stable at high temperature. We can therefore monitor ICL repair by quantitative PCR by comparing the increase in amplification of the damaged ''X'' region to that of an undamaged ''C'' region on the plasmid backbone over time (Ben-Yehoyada et al., 2009; Williams et al., 2012) (Figure S1B, right) .
Incubation of cytosol with MSH2 antibodies raised against Xenopus MSH2 protein depleted both MSH2 and MSH6 subunits of MutSa ( Figure 1C , left) but did not reduce the cytosolic levels of other MMR proteins including MLH1 and EXO1 (Figure 1C, right) . Compared to mock-depleted extracts, depletion of MutSa significantly decreased ICL repair ( Figure 1D ). Importantly, addition of recombinant MutSa WT to MSH2-depleted extracts restored ICL repair to the level of mock-depleted extracts.
Moreover, overexpression of MutSa WT in undepleted HSS increased the ICL repair efficiency ( Figure 1E ), suggesting that lesion recognition by MutSa is a rate-limiting step during RIR. These data establish that MutSa is required for ICL repair in the absence of DNA replication and transcription.
Mechanism of ICL Recognition by MutSa
MutSa discriminates aberrant DNA substrates amid a vast excess of normal DNA bases. The MSH6 subunit contributes critically to this process in at least two ways. First, the MSH6 subunit contains a highly conserved FXE motif (Figures S2A and S2B ) that functions during damage recognition (Lamers et al., 2000; Malkov et al., 1997) : the aromatic ring of the phenylalanine residue stacks with the mispaired base, whereas the carboxyl group of the glutamic acid residue hydrogen bonds with the mispaired base (Warren et al., 2007) . A single amino acid substitution of this phenylalanine residue prevents efficient recognition of mispaired bases in yeast (Bowers et al., 1999) and results in defective repair in human cell extracts (Dufner et al., 2000) .
To test the possible role of the FXE motif in MutSa-dependent repair of ICL in Xenopus extracts, we cloned and purified Xenopus mismatch binding-deficient MutSa FXE complex (Figures S2A, S2B, and S2D). First, we asked whether the F411A substitution affected MMR using a plasmid-based MMR assay in HSS extracts. We used plasmids containing a single A:C mismatch and a 15-nt gap on the 3 0 side of the A-strand (pMM1 AC ) to trigger gap-directed strand-specific MMR (Figure 2A ), as previously described (Kawasoe et al., 2016) . Repair of this plasmid occurs preferentially on the A-strand, and the correction of the A:C site to a G:C pair generates a BamHI restriction site (Figure 2A , top). Background levels of repair on the C-strand are monitored by digestion with XhoI ( Figure 2A , bottom). 60 min after incubation in mock-depleted extracts, 37% of the A:C mismatches were repaired to G:C. As anticipated, MMR was abolished in MSH2-depleted extracts. Addition of recombinant MutSa WT but not MutSa FXE restored repair (Figure 2A , top). The requirement for the FXE motif for MMR is therefore conserved in Xenopus.
Next, we determined whether the F411A substitution ablated ICL repair. As shown in Figure 2B , recombinant MutSa See also Figure S1 .
In addition to recognizing a mismatched base, MSH6 also interacts with proliferating cell nuclear antigen (PCNA). Studies using fluorescently tagged proteins show that the interaction between MSH6 and PCNA is important for the colocalization of the MutSa complex to replication factories in S. cerevisiae (Hombauer et al., 2011) and in human cells undergoing MMR (Kleczkowska et al., 2001 ). Yet, disruption of the PCNA-MSH6 interface results in a modest MMR phenotype (Shell et al., 2007) , and other PCNA-independent recruitment of MutSa to mismatches via histone methylation has also been described (Li et al., 2013) .
We used plasmid pull-down assays to ask whether MutSa was recruited to ICLs in a PCNA-independent manner. As shown in Figure 1B , the MutSa complex and PCNA were recruited to SJG-treated plasmids in HSS extracts. MutSa recruitment was not dependent on PCNA; MSH2 and MSH6 were efficiently recruited to crosslinked plasmids in PCNA-depleted extracts. Furthermore, the extent of MutSa recruitment was unaffected by supplementation of extracts with recombinant PCNA protein ( Figure 2C ). This experiment strongly suggests that MutSa can be recruited to ICLs independently of PCNA.
The interaction between MSH6 and PCNA is mediated by a PCNA interaction motif (PIP box) in MSH6 Flores-Rozas et al., 2000) . We constructed recombinant MutSa complex with a triple amino acid substitution in its conserved PIP box motif: Q(X) 2 LI(X) 2 FF ( Figures S2A, S2C , and S2D) that disrupts PCNA interaction with MutSa in vitro ( Figure S2G ). We tested the ability of this MutSa PIP to support ICL repair in MutSa-depleted extracts. We find that MutSa PIP is unable to support ICL repair ( Figure 2B ). This indicates that, whereas MSH6-PCNA interaction is not required for MutSa recruitment to ICLs, and presumably for ICL sensing, the interaction between the two is essential for coordinating downstream repair events.
ICLs Are Processed by MutLa and EXO1 Nucleases
The earliest catalytic events during ICL repair are thought to be dual endonucleolytic incisions flanking the ICL lesion in a process referred to as ''unhooking.'' However, neither the exact mechanism nor the nuclease(s) involved in the process are known for RIR. We engineered the ICL-containing plasmids with 4 unique nicking sites flanking the ICL ( Figures 3A and S3A ). We hypothesized that presenting the extract with a pre-nicked plasmid might stimulate ICL repair if the substrate resembled a physiologically relevant ICL repair intermediate. Indeed, introduction of a single nick 19 bp 5 0 to the ICL lesion stimulated repair by 4-fold. In contrast, nicks 15 or 30 bp 3 0 to the ICL or 34 bp 5 0 to the ICL failed to stimulate repair ( Figure 3B ). We conclude that incision 5 0 to the ICL is a rate-limiting step during the repair process. It further suggests that a 5 0 incision close to the ICL (19 versus 34 bp) is optimal for repair and could reflect the physiological site of incision. Finally, the asymmetry between 3 0 and 5 0 incisions could reflect the action of 2 distinct nucleases. Our evidence that MutSa is recruited to ICLs and is required for their repair prompted us to investigate the possible role of the mismatch-associated MutLa (MLH1-PMS2 heterodimer) endonuclease in ICL repair. Recruitment of MutLa to SJG-136-treated plasmids was observed following incubation of SJG-136-treated plasmid in extracts ( Figure 3C ). Notably, MLH1 recruitment was critically dependent upon MutSa, since MLH1 binding to the ICL-containing plasmid was abrogated in MSH2-depleted extracts ( Figure 3C ).
Specific antibodies against Xenopus MLH1 quantitatively depleted both MLH1 and PMS2 from extracts ( Figure 3D, left) . Importantly, MLH1 depletion did not affect the levels of MSH2 and MSH6 in the cytosol ( Figure 3D, right) , and MSH2 and MSH6 were still enriched on SJG-136-treated plasmids in MLH1-depleted extracts ( Figure S3E, left) . Removal of MLH1/ PMS2 reduced ICL repair by 50%, and addition of recombinant MutLa WT to MLH1-depleted extract restored repair ( Figure 3E ).
Therefore, MutLa is not only recruited by MutSa to ICL plasmids, it is also necessary for efficient ICL repair. The PMS2 subunit of MutLa complex contains a conserved endonuclease motif DQHA(X) 2 E(X) 4 E. Substitution of E707 to K abolishes the endonucleolytic activity associated with PMS2 and yields a strong mutator phenotype in S. cerevisiae (Smith et al., 2013) . Mutation of the corresponding residue (PMS2-E702K) in mice increases genomic mutation rates and cancer predisposition (van Oers et al., 2010) . We generated the equivalent mutation in Xenopus MutLa (MLH1-PMS2 E674K ) ( Figures   S3B-S3D ). Recombinant MutLa lacking endonuclease activity did not support ICL repair in MLH1-depleted extract ( Figure 3E ). Furthermore, overexpression of nuclease deficient MutLa complex significantly reduced ICL repair, possibly by acting as a dominant-negative ( Figure 3F ). Overexpression of recombinant MutLa complexes did not interfere with MutSa recruitment to SJG-136-treated plasmids ( Figure S3E , right). These results indicate that PMS2-associated nuclease activity is required for ICL repair. The dual incision flanking the ICL lesion during ''unhooking'' produces an oligonucleotide that remains covalently attached to DNA by the ICL adduct and is base-paired on each side of See also Figure S3 .
the ICL. During replication-coupled ICL repair, this DNA fragment is degraded with 5 0 / 3 0 polarity by the SNM1A exonuclease, presumably allowing DNA polymerases to be loaded (Wang et al., 2011) , and for other downstream repair reactions to take place.
We speculated that the 5 0 / 3 0 EXO1 exonuclease could fulfill a similar function in RIR. In an in vitro reconstituted vertebrate MMR system, EXO1 degrades the single-strand oligonucleotide harboring the mismatch (Genschel et al., 2002) . We found that EXO1 was recruited to SJG-136-treated plasmids. As is the case for MutLa, EXO1 recruitment was dependent on MutSa: EXO1 binding to the ICL-containing plasmid was reduced in MSH2-depleted extracts ( Figure 4A) . A specific antibody generated against Xenopus EXO1 quantitatively depleted EXO1 from extracts ( Figure 4B ). ICL repair was significantly reduced in EXO1-depleted HSS. This defect could be rescued by addition of EXO1
WT , but not catalytically inactive EXO1 D173A ( Figure 4C ) (Liao et al., 2011) . This demonstrates that EXO1 and its nuclease activity are required for ICL repair in the absence of DNA replication and transcription.
To evaluate the specific contribution of EXO1 during ICL repair, we conducted in vitro nuclease assays (Wang et al., 2011) . First, we purified the catalytic domain of human EXO1 (EXO1 352 ) from E. coli as previously described (Shi et al., 2017) . EXO1 352 harbors robust nuclease activity in vitro but lacks its C-terminal region ( Figure S4A ), important for making connections with various protein binding partners including MSH2, MLH1, PCNA, and RPA (Shi et al., 2017) .
Duplex oligonucleotides containing a single SJG-136 ICL lesion are easily distinguished by size from uncrosslinked duplex on a denaturing polyacrylamide gel ( Figure S4B) . Similarly, the reaction products upon incubation with EXO1 352 can be visualized and identified. We generated control duplex DNA with only one free 5 0 end available for processing (the 5 0 end of the other strand blocked by addition of a biotin moiety). This template is efficiently processed by EXO1 352 from the biotin-free 5 0 end in the 5 0 to 3 0 direction as anticipated ( Figure 4D , left). Exonucleolytic processing was abolished when both ends of the duplex are blocked with biotin, confirming that under these experimental conditions, only the exonuclease activity contributes to the processing of the DNA substrates. When EXO1 352 was incubated with similar ds-DNA oligonucleotides containing a single SJG-136 ICL lesion, EXO1 352 was able to initiate processing of the substrate from an available 5 0 end. However, EXO1 processing was blocked by the ICL lesion ( Figure 4D , right). EXO1 352 is therefore unable to bypass an ICL under these conditions.
Incubation of plasmids harboring ICL lesions activates the RPA-ATR-pChk1 branch of the DNA damage response (Figure S1G) . Next, we assessed the role of RPA in ICL repair. Trimeric RPA protein complex was depleted using an antibody generated against RPA1. Depletion of RPA from HSS extracts completely abolished ICL repair. ICL repair was restored by addition of recombinant Xenopus trimeric RPA complex ( Figures  S4C-S4E ). This is consistent with our previous studies in which we reported a requirement for RPA in ICL repair in LSS extracts (low-speed supernatant) treated with geminin and roscovitine to inhibit replication (Ben-Yehoyada et al., 2009 ). We predicted that RPA binding to crosslinked plasmids during ICL repair would occur primarily after ICL recognition and initiation of ICL unhooking events. We found that MSH2, MSH6, and MLH1 were loaded to similar levels to SJG-136-treated plasmids following incubation in mock-and RPA-depleted extracts (Figure S4F) . This result supports a model in which MutSa and MutLa play early roles during ICL repair, preceding nucleolytic events during the repair.
The Efficiency of RIR Is Influenced by ICL Structure
In replicating extracts, ICLs are sensed by a translocating replisome that stalls at the ICL. In RIR, we suggest ICL sensing is dependent on distortion of the DNA helix at the lesion. To test this idea, we compared the kinetics of repair between chemically related trimethylene ICLs in two distinct structural conformations: the more distorting 5 0 -GpC-ICL (Dooley et al., 2003) and the less distorting 5 0 -CpG-ICL (Dooley et al., 2001 ) ( Figures 5A and S5A ). Both ICLs were ligated into a pEGFP vector backbone ( Figure S5B ). We found that the more distorting ICL induced a stronger ATR checkpoint activation (Figure 5B) . Furthermore, repair of the more distorting lesion was 40% more efficient than the less distorting lesion ( Figure 5C ). We next asked whether repair of these ICLs was dependent upon MutSa. As shown in Figure 5D , repair of both trimethylene crosslinks displayed a similar requirement for MSH2. Thus, MutSa is able to recognize structurally distinct ICL lesions.
Finally, we monitored repair of a chemically distinct nitrogen mustard-like ICL lesion ( Figures 5E and S5A ). This NM-ICL is generated within the major groove with minimal distortion of the DNA helix, allowing the DNA to maintain B-DNA conformation (Guainazzi et al., 2010; Mukherjee et al., 2014) . Interestingly, even after 3 hr of incubation there was no detectable repair of this NM-ICL ( Figure 5E ). This supports our notion that ICL recognition in RIR depends on DNA distortion and is consistent with a previous report, which indicates that the repair of NM-ICLs is entirely dependent on replication (Rä schle et al., 2008) .
DISCUSSION
MutSa Is a Bona Fide ICL Sensor
The mechanism(s) by which ICLs are sensed and repaired in non-dividing cells has been difficult to elucidate. In this study, we used Xenopus HSS extracts, which do not replicate or transcribe, to identify eukaryotic MMR complex, MutSa (MSH2-MSH6), as a sensor of ICL lesions. Our conclusion is supported by the following observations. First, MutSa was recruited to plasmids containing ICL lesions ( Figures 1A and 1B) . Second, MutSa carrying its mismatch binding FXE motif was required for repair of trimethylene ICLs ( Figure 2B ). Third, binding of MutSa to ICL was required for recruitment of downstream repair proteins including MutLa ( Figure 3C ) and EXO1 ( Figure 4A) .
We conclude that binding of MutSa to ICLs precedes nucleolytic processing and thus acts at an early step in ICL repair. Moreover, overexpression of MutSa in extracts enhanced ICL repair efficiency ( Figure 1E ), further suggesting MutSa senses ICLs, and that such sensing is a rate-limiting step in repair. We observe that MutSa-dependent ICL repair has slower kinetics than the repair of mismatches in Xenopus extracts (Kawasoe et al., 2016; Radman, 2016) . We surmise that the complexity of the ICL lesion, which requires two rounds of repair synthesis during RIR, could account for this difference.
Importantly, we find that structurally distinct ICLs were repaired with varying efficiencies. Trimethylene-ICLs, which significantly distort DNA, were repaired with robust efficiency, in contrast to non-distorting NM-like ICLs, which had no detectible repair ( Figures 5C and 5E ). This indicates that ICL repair by RIR is critically dependent on ability of the ICL lesion to be recognized by DNA damage sensor proteins. Thus, repair of ICLs in G0/G1 utilizes a fundamentally different mechanism than ICL repair during S-phase, when lesion sensing occurs by replisomes stalled at ICLs irrespective of crosslink structure. Moreover, ICL recognition by MutSa during RIR may also be influenced by sequence context, as has been proposed for MMR (Mazurek et al., 2009) .
Of note, MutSa (MSH2-MSH6) is one of two MMR sensors that operate during MMR in vertebrates. The other is MutSb (MSH2-MSH3), which is about 10 times less abundant than MutSa in mammalian cells and has higher specificity for recognizing larger IDLs and branched DNA substrates (Genschel et al., 1998) . Depletion of MSH2 from extracts quantitatively depleted MSH6 and MSH3. Our depletion-rescue experiments with recombinant MutSa, which fully rescues ICL repair, helps assign the specificity of ICL recognition to MutSa ( Figure 1D) . In mammalian cells, MutSb along with the global genome nucleotide excision repair sensor, XPC (xeroderma pigmentosum complementation group C) have been linked to psoralen ICL repair (Muniandy et al., 2009; Thoma et al., 2005; Zhang et al., 2002; Zhao et al., 2009) . However, how these complexes contribute to the repair of ICLs remains unclear.
We were unable to detect direct binding of MutSa to SJG-136-treated oligonucleotides using electrophoretic mobility shift assay (EMSA) experiments. This could be due to the design of the oligo duplex itself, which is restricted in length (20 bases) to ensure SJG-136 generates a single ICL and to avoid the formation of secondary structures, since the duplex must be almost exclusively be composed of A and T nucleotides. While our data using the mismatch binding deficient (FXE) mutant MutSa (Figure 2B ) strongly suggest that MutSa binding to DNA is critical for ICL repair, we cannot formally rule out that additional proteins participate in recruiting MutSa to ICLs.
The Role of PCNA during RIR Previously, we reported that PCNA is an essential RIR factor. We showed that PCNA ubiquitinylated at lysine (K164) is required to recruit Polk to ICL sites for repair synthesis (Williams et al., 2012) . The experiments described here indicate that PCNA is not essential for MutSa recruitment to ICLs ( Figure 2C ). However, we find a requirement for interaction between MutSa and PCNA for ICL repair ( Figure 2B ). This suggests that PCNA may help retain MutSa at damage sites, or perhaps enhance MutSa's damage recognition specificity, as has been suggested during MMR Flores-Rozas et al., 2000; Kleczkowska et al., 2001) . Our data show that PCNA plays an upstream role during ICL repair, in addition to supporting Polk recruitment for repair synthesis.
We also probed the requirement for binding between PCNA and components of the MMR machinery by generating mutations in the interdomain connector loop (IDCL) of PCNA. Mutations in this region abrogate interactions with MSH6 and PMS2 in vitro, and cause MMR defects in yeast (Lee and Alani, 2006) . We made the equivalent mutations in Xenopus PCNA L126A,I128A ( Figures S2E and S2F) . However, we were not able to determine the contribution of the PCNA:MutSa interface to ICL repair using the this mutant, since binding between MutSa WT and PCNA L126A,I128A was enhanced, as measured by co-immunoprecipitation, compared to binding between MutSa WT and PCNA WT ( Figure S2G ). Accordingly, both PCNA WT and PCNA L126A,I128A were able to rescue ICL repair defects in PCNA-depleted extracts ( Figures S2H and S2I ).
Insights into Nucleolytic Processing of ICLs by MutLa and EXO1
Following sensing, an ICL is thought to be processed in two consecutive nucleolytic steps. First, dual incisions surrounding the ICL are made to produce an ''unhooked'' oligonucleotide, which is covalently tethered to the DNA by the ICL adduct. The unhooked lesion is then resected in a ''trimming'' reaction that facilitates synthesis past the adduct by translesion synthesis polymerases by eliminating the need for displacement synthesis (Roy et al., 2016) . In replication-coupled ICL repair the XPF-ERCC1 endonuclease and SLX4 promote unhooking of ICLs (Klein Douwel et al., 2014) , and the SNM1A exonuclease has been proposed to process unhooked ICL lesions (Wang et al., 2011) . We investigated the role of these nucleolytic reactions in RIR. We used nicked plasmids to identify that a 5 0 incision 19 base pairs away from an ICL lesion was able to stimulate repair by 4-fold. This is in contrast to nicks placed 15 or 30 bp 3 0 to the ICL or 34 bp 5 0 to the ICL, all of which failed to stimulate repair ( Figure 3B ). This experiment demonstrates a striking mechanistic difference between RIR and MMR. MMR is stimulated symmetrically by either a 5 0 or a 3 0 nick in vitro (Constantin et al., 2005; Varlet et al., 1996) . Our results also suggest that 5 0 incision is a rate-limiting step during RIR, and that 2 distinct nucleases are required during ICL repair. Depletion-rescue experiments with MutLa strongly suggest that MutLa promotes one or both of these incisions. However, because it is generally thought that MutLa requires a pre-existing nick and interaction with PCNA to stimulate its otherwise latent endonuclease activity, it is possible that another, as yet unidentified nuclease, is responsible for the initial incision.
Our discovery that MutSa and MutLa participate in ICL repair highlights the versatile roles DNA repair proteins play in genome maintenance. This idea is further exemplified by our finding that EXO1 is required during RIR. EXO1 is a 5 0 / 3 0 exonuclease that is not only involved in MMR, but also plays critical roles in double-strand break repair and telomere maintenance (Tran et al., 2004) . In all of these roles, EXO1 catalyzes digestion of DNA by hydrolyzing phosphodiester bonds between adjoining normal nucleotides. The requirement for EXO1's nuclease activity during ICL repair ( Figure 4C ) suggests that EXO1 could process complex, chemically modified DNA substrates, including crosslinked bases. However, our in vitro experiments in which EXO1 352 was unable to bypass an ICL lesion strongly suggests that EXO1 alone cannot efficiently process ICLs ( Figure 4D ). However, it is conceivable that ICL processing by EXO1 requires association with other proteins through its C terminus.
During replication-coupled ICL repair, SNM1A has been proposed to operate similarly to EXO1 in processing unhooked ICL lesions (Wang et al., 2011) . In addition, there is evidence that the FAN1 nuclease can digest past ICL-containing oligonucleotides in vitro (Pizzolato et al., 2015; Wang et al., 2014) . However, we find that FAN1 depletion in Xenopus HSS extracts has no effect on ICL repair (unpublished data).
Conclusions
DNA crosslinking agents are among the most widely prescribed anti-cancer drugs used in the clinic. Yet, acquired resistance remains is a significant limitation of these drugs (Deans and West, 2011) . It seems likely that alterations to pathways that contribute to the repair of ICLs, the principle cytotoxic lesion generated by these drugs, may underlie acquired resistance. It is therefore critical to fully understand how cells respond to and repair ICLs.
We provide compelling evidence that the MMR pathway contributes to ICL repair. This is in agreement with a recent study that used an unbiased proteomic approach to study protein recruitment to psoralen-ICLs using quantitative mass spectrometry. This study revealed that MSH2, MSH6, PMS2, and EXO1 associate with crosslinked chromatin (Rä schle et al., 2015) . Importantly, recruitment of these proteins was resistant to geminin, suggesting that MMR proteins may play a role in ICL repair both in and beyond G0/G1 phase. Indeed, requirement for MSH2 and EXO1 has been reported in repair of nitrogen mustard ICLs in S-phase yeast (Barber et al., 2005) , and in S-phase mammalian cells defective in the FA pathway (Huang et al., 2011) .
In this study, we provide mechanistic insights into how MMR proteins cooperate to accomplish ICL repair ( Figure 6 ). We propose that ICLs that are recognized by MutSa are processed by MutLa and EXO1 in an incision-excision reaction, followed by DNA synthesis process that requires PCNA and Polk. Further, our work stresses the importance of distinguishing between structurally distinct ICLs, which may be repaired in overlapping and/or divergent ways. Future experiments should address whether the sequence context of ICLs influences ICL recognition and repair.
EXPERIMENTAL PROCEDURES
Xenopus Cell-free Extract and Depletions Xenopus laevis frogs were handled in accordance with guidelines provided by the Institutional Animal Care and Use Committee at Columbia University, protocol AAAK0551. For details regarding the preparation of cell-free extracts and depleted extracts, see Supplemental Experimental Procedures.
Preparation ICL Plasmids SJG-136-treated plasmids were prepared by incubating pBS with indicated concentrations of SJG-136 (NCI/Spriogen LTD) in 50 mM triethanolamine and 2 mM EDTA, overnight at 37 C. Plasmids were ethanol precipitated and resuspended in water. The quality and quantity of plasmids recovered were analyzed by agarose gel electrophoresis with ethidium bromide, Nanodrop measurement, and qPCR. The amount of plasmid used in plasmid pull-down experiments was normalized accordingly. The preparation of plasmids containing a single SJG-136, trimethylene, or NM-like ICL lesion is described in detail in Supplemental Experimental Procedures.
ICL Repair and lac Repressor Plasmid Pull-Down Experiments in Xenopus Extracts
Lac repressor plasmid pull-down assays in undepleted and depleted HSS extracts were performed as described previously (Williams et al., 2012) . ICL repair assays in HSS were performed essentially as describe previously (Ben-Yehoyada et al., 2009; Williams et al., 2012) . Each of these assays, as well as the MMR assay of a site-specific A:C mispair is described in detail in Supplemental Experimental Procedures.
PCNA/Polκ
Replication Independent ICL Repair ICLs can be recognized and repaired in the absence of replication. The MutSa complex senses and binds ICL lesions and recruits downstream repair proteins including the MutLa endonuclease, PCNA, and EXO1 exonuclease. The ICL lesion is repaired through a multi-step excision resynthesis reaction. The latter requires Polk and monoubiquitinated PCNA.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism 7 software using paired Student's t test or ANOVA. Data are annotated as ns = p > 0.05; *p % 0.05; **p % 0.01; ***p % 0.001; ****p % 0.0001.
Protein Expression and Purification
Recombinant MutSa, MutLa, RPA, PCNA, and EXO1 were purified as described in Supplemental Experimental Procedures. 
Reagents
